One-Year Outcomes After Different Treatments for Acute Cholecystitis in Patients Aged 70 and Older

What this Trial Is About

The GOLDENEYE study is an international and multicenter observational research focused on patients aged 70 years and older diagnosed with acute cholecystitis. It aims to compare outcomes from different management strategies for this condition, recognizing the unique challenges in treating elderly patients with multiple health issues. The study seeks to provide evidence to improve treatment approaches and patient care in this growing elderly population. This study observes various treatment methods including supportive care with antibiotics, early or delayed removal of the gallbladder cholecystectomy, percutaneous gallbladder drainage, and EUS-guided gallbladder drainage. Instead of assigning treatments randomly, the study uses a method called propensity score matching to fairly compare outcomes among patients receiving these different treatments. Participants will be followed for one year to track additional treatments, hospital readmissions, outpatient visits, quality of life, and survival. Data are collected securely through a dedicated platform across multiple centers. The study emphasizes patient-centered outcomes and aims to provide reliable information to guide future care decisions for elderly patients with acute cholecystitis.

One-year Outcomes by Index Treatment in Elderly Patients With Acute Cholecystitis